← Back to Analyst Consensus 
VTGN Hold
Vistagen Therapeutics, Inc.
Current Price —
Implied Upside —
Analysts 8
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 11, 2026 (16 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Dec 17, 2025 | William Blair | downgrade | Outperform → Market Perform | $0 | 48% |
| Dec 17, 2025 | Maxim Group | downgrade | Buy → Hold | $0 | 42% |
| Dec 17, 2025 | Jefferies | downgrade | Buy → Hold | $0.9 | 52% |
| Dec 7, 2023 | Jefferies | upgrade | Hold → Buy | $15 | 52% |
| Nov 14, 2023 | Stifel | initiate | — → Buy | $12 | 53% |
| Sep 5, 2023 | Maxim Group | maintain | Buy → Buy | $30 | 42% |
| Aug 7, 2023 | Maxim Group | upgrade | Hold → Buy | $30 | 42% |
Price Target Trend
May 6, 2026 Oct 26, 2026
EPS Estimates
0y —
+1y —
0q —
+1q —
Cross-Platform Signals
No cross-platform signals in the last 90 days